NETEC COVID-19 Webinar Series (11/05/21): Monoclonal Antibody Therapy in Residential Healthcare Settings

Document Viewer

Share this page:

Title

NETEC COVID-19 Webinar Series (11/05/21): Monoclonal Antibody Therapy in Residential Healthcare Settings

Description

Join us Friday, November 5th, at 1 pm EST for a NETEC COVID-19 Webinar Series presentation, Monoclonal Antibody Therapy in Residential Healthcare Settings. Topics will include the role monoclonal antibody (mAb) therapy is playing in treating COVID-19 in residential healthcare settings, current use case applications, and a discussion highlighting a residential healthcare mAB program currently operating in Nebraska.

Creator

Date Last Updated (Year-Month-Day)

2021-11-05

Duration

Friday, November 5, 2021 | 1:00 PM EST

Objectives

SPEAKERS

Andrew B. Watkins, PharmD, BCIDP
Dr. Andrew B. Watkins is the pharmacy coordinator for the Nebraska Antimicrobial Stewardship Assessment and Promotion Program (ASAP) as well as an antimicrobial stewardship outreach pharmacist within the Nebraska Medicine Antimicrobial Stewardship Program.

Kate Tyner, BSN, RN, CIC
Kate Tyner is an infection preventionist and the supervisor of the Nebraska Infection Control Assessment and Promotion Program (ICAP)

Muhammad Salman Ashraf, MBBS
Dr. Ashraf, is the medical director for the Nebraska Infection Control Assessment and Promotion Program (ICAP). He is also the co-medical director of the Nebraska Antimicrobial Stewardship Assessment and Promotion Program (ASAP) and an Associate Professor in the Division of Infectious Diseases, Department of Internal Medicine, at University of Nebraska Medical Center, Omaha (UNMC).

NOTE: Continuing Education Units will not be provided for this NETEC webinar activity.

Event Type

Webinar, register at link below.